中财网 中财网股票行情
博瑞医药(688166)财务分析指标    年份：
截止日期2024-09-302024-06-302024-03-312023-12-312023-09-30
营业总收入(万元)97682.5765768.8434013.31117951.7591487.78
营业收入(万元)97682.5765768.8434013.31117951.7591487.78
营业总成本(万元)79833.9456386.3826734.12100428.0269959.92
营业成本(万元)41024.1529401.7014569.4152141.4037893.92
净利润(万元)14233.807122.816178.4817606.6518688.36
归属于母公司的净利润(万元)17740.8810636.476406.9920246.6019179.07
营业利润(万元)16835.099439.727069.1719024.4419795.65
利润总额(万元)16807.639430.637058.7018877.0119768.83
少数股东损益(万元)-3065.12-2413.77-226.01-2904.24-1505.00
基本每股收益(元)0.42(元)0.25(元)0.15(元)0.48(元)0.45(元)
稀释每股收益(元)0.42(元)0.25(元)0.15(元)0.48(元)0.45(元)
非经常性损益(万元)--112.85-14.451615.34--
扣除非经常性损益后净利润(万元)17362.5810523.626421.4418631.2718770.49
总资产(万元)487853.28523066.82508750.69503183.14496578.35
总负债(万元)253619.31281652.52261334.18261424.78252504.22
归属于母公司股东权益合计(万元)235238.11238766.25242745.71236861.54237787.75
股东权益合计(万元)234233.97241414.29247416.51241758.35244074.13
实收资本(股本)(万元)42246.6642246.6642246.6642246.6542246.54
资本公积(万元)94938.19105548.31105713.31105713.20105599.02
未分配利润(万元)96732.6389628.2389450.9483043.9582848.21
经营活动产生的现金流量净额(万元)11958.9715122.0314846.1819476.559882.84
经营活动现金流入小计(万元)90402.3363939.6537572.30107588.4976874.60
经营活动现金流出小计(万元)78443.3648817.6222726.1288111.9466991.76
投资活动产生的现金流量净额(万元)-42487.31-29174.57-13837.87-43985.36-36758.77
投资活动现金流入小计(万元)9828.198766.95--13390.355219.97
投资活动现金流出小计(万元)52315.5037941.5213837.8757375.7041978.74
筹资活动产生的现金流量净额(万元)-17376.7111569.34-1097.146161.126668.38
筹资活动现金流入小计(万元)59596.2851606.2826294.6674623.2461927.58
筹资活动现金流出小计(万元)76972.9940036.9427391.8068462.1255259.20
期末现金及现金等价物余额(万元)49332.4094812.2797096.1997104.0894585.09
最后修改日期2024-10-302024-08-262024-04-272024-04-272023-10-26
↑返回页顶↑

转至博瑞医药（688166）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。